Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

People with color blindness may be less able to spot an early sign of bladder cancer, making them likelier to be diagnosed ...

Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

Study suggests inability to identify blood in urine may delay diagnosis and reduce surviva ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

What Is Transurethral Resection of Bladder Tumor (TURBT)? If you have bladder cancer or suspected bladder cancer, your doctor has probably told you that you need a transurethral resection of the ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

On Jan. 20, 2026, investors weigh ImmunityBio’s sharp rally on new FDA feedback around its bladder cancer plans.